Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Your donations help support people living with type 1 diabetes today and fund the best treatment and cure research, no matter where in the world it takes place.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
Join the type 1 diabetes community and come together, raise awareness and vital funds for T1D. Every step taken and pound raised directly supports us to fund our life-changing research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > News & events > News > Rhea Norwood becomes new ambassador for Breakthrough T1D
Actor Rhea Norwood has been announced as the newest ambassador for Breakthrough T1D. Since being diagnosed with type 1 diabetes (T1D) in 2022, Rhea has used her platform to raise awareness and connect with others facing similar challenges.
Known for her role as Imogen Heaney in Heartstopper and, more recently, as Sally Bowles in the West End production of Cabaret, Rhea now brings her passion and dedication to her role as ambassador, with the goal of inspiring and supporting young people living with T1D.
Rhea’s role as ambassador will focus on highlighting the unique needs of young people managing T1D, whose daily lives, education, work and social lives are often impacted by the condition.
Rhea says:
“As a young woman living with type 1 diabetes, I have experienced firsthand the daily challenges and complexities this condition brings. I am excited to join Breakthrough Type One and bring a passion for raising awareness, supporting others in our community, and advocating for those affected by Type 1 diabetes. I’m especially passionate about opening up conversations about the difficulties women navigate with this condition. Ultimately, I hope I can show that we can lead full, empowered lives with the right support and determination.”
Karen Addington, CEO of Breakthrough T1D, adds:
“Rhea’s authenticity and influence make her a powerful voice for young people living with T1D. We’re thrilled to have her as an ambassador and look forward to working together to raise awareness and create a more inclusive, supportive environment for everyone living with the condition.”
Meet our celebrity supporters including Nina Wadia, James Norton and Sheku Kanneh-Mason.
Our ambassador James Norton read a CBeebies Bedtime Story in Diabetes Awareness Week.
Find out about Marcel's diagnosis with type 1 diabetes and his hopes for a cure.
A new paper co-authored by Breakthrough T1D, Diabetes UK, and Kidney Research UK has identified six themes to tackle diabetic kidney disease.
Our highlights from a year full of breakthroughs in type 1 diabetes research and advocacy.
The framework aims to encourage UK researchers to consider different sexes (biological attributes) and genders (roles, behaviours and identity in society) to address gaps in health data.
Our Access for All report, launched today, highlights how far we’ve come with advancements in diabetes technology, but shows that many people still face barriers when trying to access T1D technology.
Immunotherapy, beta cell replacement, smart insulins – we’re driving research in the most promising areas to find cures and better treatments for type 1 diabetes.
